NIH-funded research Sbir 2 grant

Developing new drugs to treat obesity by targeting specific enzymes.

Official title: Discovery and optimization of novel, selective HDAC11 inhibitors for the treatment of obesity and related diseases.

Funded at Myracle Therapeutics INC · NIH-10921027 · Data updated 2026-11-12

This study is looking at new ways to help people with obesity by targeting a specific enzyme called HDAC11, which affects how our body uses fat, with the hope of improving metabolism and overall health.

More Obesity research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionMyracle Therapeutics INC
NIH-funded
Lab location1 site (East Hanover, United States)
Project startJuly 25, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$324,466
NIH project number1R44DK139886-01
Project IDNIH-10921027 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals struggling with obesity or related metabolic disorders.

Less likely to help

Patients who are not affected by obesity or metabolic diseases may not receive any benefit from this research.

What this research studies

This research focuses on creating selective inhibitors for the enzyme HDAC11, which may help improve metabolic health and treat obesity. By understanding how HDAC11 affects fat tissue, the researchers aim to enhance energy expenditure and reduce fat dysfunction. The approach involves studying the effects of these inhibitors on brown and white adipose tissues, which play crucial roles in metabolism. Patients may benefit from new therapeutic options that target the underlying mechanisms of obesity and related metabolic diseases.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments for obesity and improve metabolic health in patients.

How similar studies have gone: Other research has shown promise in targeting metabolic pathways for obesity treatment, indicating potential success for this approach.

Where this research is happening

  • Myracle Therapeutics INC
    East Hanover, United States
    Active

Researchers

  • Principal investigator: Bell, Dawn — Myracle Therapeutics INC
  • Study coordinator: Bell, Dawn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.